---
document_datetime: 2023-09-21 18:39:27
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/mysildecard-epar-all-authorised-presentations_en.pdf
document_name: mysildecard-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7773332
conversion_datetime: 2025-12-23 04:24:21.936189
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size                  |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|----------------------------|
| EU/1/16/1134/001 | Mysildecard       | 20 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 90 tablets                 |
| EU/1/16/1134/002 | Mysildecard       | 20 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 300 tablets                |
| EU/1/16/1134/003 | Mysildecard       | 20 mg      | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 90 x 1 tablets (unit dose) |